Modeling of proteasomal subunit mutations in MM cell lines indicated two somatic mutations in the subunit β type 5 (PSMB5) gene (i.e., T21A and A49V) that altered their binding pocket causing a reduced binding affinity for bortezomib (Figure 4) [159]. Here, PSMB5 is linked to Miyoshi myopathy.